[
    {
        "@id": "https://pd.sciai.eu/np/2500021/RAwgNtWerb7FzNyIwHQ73hI8fhK3XlrKUWgMqE2IOcQ50/provenance",
        "@graph": [
            {
                "@id": "https://pd.sciai.eu/np/2500021/RAwgNtWerb7FzNyIwHQ73hI8fhK3XlrKUWgMqE2IOcQ50/assertion",
                "http://www.w3.org/2000/01/rdf-schema#comment": [
                    {
                        "@value": "Evidence-state label of the citing paper within the GLP-1 pilot corpus (207 papers; supported / contested / single-source / unlabeled), computed from cross-paper agreement over kg.assertions with author-overlap independence exclusions (v2, 2026-09-21)."
                    }
                ],
                "http://www.w3.org/ns/prov#wasDerivedFrom": [
                    {
                        "@id": "https://pubmed.ncbi.nlm.nih.gov/40220748/"
                    }
                ],
                "http://www.w3.org/ns/prov#wasGeneratedBy": [
                    {
                        "@id": "https://sciai.eu/#sciai-lab"
                    }
                ],
                "https://pd.sciai.eu/ontology/property/evidenceStateLabel": [
                    {
                        "@value": "single-source"
                    }
                ],
                "https://pd.sciai.eu/ontology/property/extractedAt": [
                    {
                        "@value": "2026-09-07T05:17:32.123070+00:00",
                        "@type": "http://www.w3.org/2001/XMLSchema#dateTime"
                    }
                ],
                "https://pd.sciai.eu/ontology/property/extractionSchema": [
                    {
                        "@value": "universal_pd_v5"
                    }
                ],
                "https://pd.sciai.eu/ontology/property/paperType": [
                    {
                        "@value": "narrative_review"
                    }
                ],
                "https://pd.sciai.eu/ontology/property/verbatimContext": [
                    {
                        "@value": "EXENATIDE-PD3 is described as a phase 3 clinical trial testing exenatide in Parkinson’s disease."
                    }
                ]
            }
        ]
    },
    {
        "@id": "https://pd.sciai.eu/np/2500021/RAwgNtWerb7FzNyIwHQ73hI8fhK3XlrKUWgMqE2IOcQ50/pubinfo",
        "@graph": [
            {
                "@id": "https://pd.sciai.eu/np/2500021/RAwgNtWerb7FzNyIwHQ73hI8fhK3XlrKUWgMqE2IOcQ50",
                "http://purl.org/dc/terms/created": [
                    {
                        "@value": "2026-11-06T23:32:25+00:00",
                        "@type": "http://www.w3.org/2001/XMLSchema#dateTime"
                    }
                ],
                "http://purl.org/dc/terms/creator": [
                    {
                        "@id": "https://pd.sciai.eu/np/bot/sciai-kg-publisher"
                    }
                ],
                "http://purl.org/dc/terms/license": [
                    {
                        "@id": "https://creativecommons.org/licenses/by-sa/4.0/"
                    }
                ],
                "http://www.w3.org/2000/01/rdf-schema#comment": [
                    {
                        "@value": "Machine-generated by the sciai-lab KG publisher bot (https://pd.sciai.eu/np/bot/sciai-kg-publisher) from the sciai-lab knowledge graph (kg.assertions); not manually authored. Responsible contact: Johannes Keizer (https://orcid.org/0009-0008-6409-2596)."
                    }
                ],
                "http://www.w3.org/ns/prov#wasAttributedTo": [
                    {
                        "@id": "https://sciai.eu/#sciai-lab"
                    }
                ]
            },
            {
                "@id": "https://pd.sciai.eu/np/2500021/RAwgNtWerb7FzNyIwHQ73hI8fhK3XlrKUWgMqE2IOcQ50/sig",
                "http://purl.org/nanopub/x/hasAlgorithm": [
                    {
                        "@value": "RSA"
                    }
                ],
                "http://purl.org/nanopub/x/hasPublicKey": [
                    {
                        "@value": "MIIBIjANBgkqhkiG9w0BAQEFAAOCAQ8AMIIBCgKCAQEAmbH3DJ0b7gHODI7sDgcVyu5oU1CCZ/ExuejhS0LiNfnjx6SFzKWZDYEvakKaDFZUNkoFzdjVVhBZfV6MKxv3Jh8xzq876JjGkFoNqIO6tUTmMtkpP2eS26/QTPuoAn4psuSIgNCvAk/98cL1wpWS9kl/WNb+1L7RL8mrN72f0P3we555ShsIRgHD8hQJM3cK/naK4JBm350q1nzfUYLhMHUriRlJyXw7JbRnpAAlKCvoIvU4a9X5XM3ULr9ochcIlw7HgZdqD/hrL6CX0c+s0huvKK9SWTkcsO1Xp4oacwUlgPVYFg7OQiyB/WOIV7iXhYlP92s0+KSqX8XJoU2jCQIDAQAB"
                    }
                ],
                "http://purl.org/nanopub/x/hasSignature": [
                    {
                        "@value": "mP6kn7IT9xzAAV34CW0UH7ZdZnP8HAvNCHrx0W9O/fqHPhg1a0XVtHZCnY4oOL5uAiSlUxOEDxt2spBnyo83zH463Qz7fbAUSJXFHEs98UhzGJBexp2MVy7WXUHiQrKDrsx024hj5gJq2hPvuRukuNgxvl2/xmZ1W4yqrx2IrhQ/KUEzxzt7LVJ9O1pfcMBy4nz/0nscdlkb4/GX7u7vw849guo0K7+1Z4IVAIvcjLgNRR2zxeQi68CFfJhJAutKwg30zPkZRVQHY0Zy2oqC543gy43ssdbWDE+Cr+CusvBISL9ylbLbyjHYZVegfIyKumUZuEuSu88AWlIFyLNwZQ=="
                    }
                ],
                "http://purl.org/nanopub/x/hasSignatureTarget": [
                    {
                        "@id": "https://pd.sciai.eu/np/2500021/RAwgNtWerb7FzNyIwHQ73hI8fhK3XlrKUWgMqE2IOcQ50"
                    }
                ],
                "http://purl.org/nanopub/x/signedBy": [
                    {
                        "@id": "https://pd.sciai.eu/np/bot/sciai-kg-publisher"
                    }
                ]
            }
        ]
    },
    {
        "@id": "https://pd.sciai.eu/np/2500021/RAwgNtWerb7FzNyIwHQ73hI8fhK3XlrKUWgMqE2IOcQ50/assertion",
        "@graph": [
            {
                "@id": "https://pd.sciai.eu/np/2500021/RAwgNtWerb7FzNyIwHQ73hI8fhK3XlrKUWgMqE2IOcQ50/claim",
                "@type": [
                    "https://pd.sciai.eu/ontology/property/Assertion"
                ],
                "https://pd.sciai.eu/ontology/property/assertionId": [
                    {
                        "@value": "2500021",
                        "@type": "http://www.w3.org/2001/XMLSchema#integer"
                    }
                ],
                "https://pd.sciai.eu/ontology/property/confidence": [
                    {
                        "@value": "0.95",
                        "@type": "http://www.w3.org/2001/XMLSchema#decimal"
                    }
                ],
                "https://pd.sciai.eu/ontology/property/effectDirection": [
                    {
                        "@value": "unknown"
                    }
                ],
                "https://pd.sciai.eu/ontology/property/evidenceTier": [
                    {
                        "@value": "3",
                        "@type": "http://www.w3.org/2001/XMLSchema#integer"
                    }
                ],
                "https://pd.sciai.eu/ontology/property/hasObject": [
                    {
                        "@id": "https://pd.sciai.eu/ontology/entity/CLU%3Aphase-3-clinical-trial"
                    }
                ],
                "https://pd.sciai.eu/ontology/property/hasRelation": [
                    {
                        "@id": "https://pd.sciai.eu/ontology/relation/type_of"
                    }
                ],
                "https://pd.sciai.eu/ontology/property/hasSubject": [
                    {
                        "@id": "https://pd.sciai.eu/ontology/entity/SELF%3Aexenatide%20pd3"
                    }
                ]
            },
            {
                "@id": "https://pd.sciai.eu/ontology/entity/CLU%3Aphase-3-clinical-trial",
                "@type": [
                    "https://pd.sciai.eu/ontology/type/Concept"
                ],
                "http://www.w3.org/2000/01/rdf-schema#label": [
                    {
                        "@value": "Phase 3 clinical trial"
                    }
                ]
            },
            {
                "@id": "https://pd.sciai.eu/ontology/entity/SELF%3Aexenatide%20pd3",
                "@type": [
                    "https://pd.sciai.eu/ontology/type/Concept"
                ],
                "http://www.w3.org/2000/01/rdf-schema#label": [
                    {
                        "@value": "EXENATIDE-PD3"
                    }
                ],
                "https://pd.sciai.eu/ontology/relation/type_of": [
                    {
                        "@id": "https://pd.sciai.eu/ontology/entity/CLU%3Aphase-3-clinical-trial"
                    }
                ]
            }
        ]
    },
    {
        "@id": "https://pd.sciai.eu/np/2500021/RAwgNtWerb7FzNyIwHQ73hI8fhK3XlrKUWgMqE2IOcQ50/Head",
        "@graph": [
            {
                "@id": "https://pd.sciai.eu/np/2500021/RAwgNtWerb7FzNyIwHQ73hI8fhK3XlrKUWgMqE2IOcQ50",
                "http://www.nanopub.org/nschema#hasAssertion": [
                    {
                        "@id": "https://pd.sciai.eu/np/2500021/RAwgNtWerb7FzNyIwHQ73hI8fhK3XlrKUWgMqE2IOcQ50/assertion"
                    }
                ],
                "http://www.nanopub.org/nschema#hasProvenance": [
                    {
                        "@id": "https://pd.sciai.eu/np/2500021/RAwgNtWerb7FzNyIwHQ73hI8fhK3XlrKUWgMqE2IOcQ50/provenance"
                    }
                ],
                "http://www.nanopub.org/nschema#hasPublicationInfo": [
                    {
                        "@id": "https://pd.sciai.eu/np/2500021/RAwgNtWerb7FzNyIwHQ73hI8fhK3XlrKUWgMqE2IOcQ50/pubinfo"
                    }
                ],
                "@type": [
                    "http://www.nanopub.org/nschema#Nanopublication"
                ]
            }
        ]
    }
]